Short answer · Medically reviewed summary · Last updated: 2026-05-08
The medical classification for Victims of Thalidomide is primarily coded under ICD-10-CM code Q83.8 (Other congenital malformations of breast) or more broadly under external cause codes like Y43.2 (Adverse effects of drugs), while the legacy ICD-9-CM code is 760.72 (Noxious influences affecting fetus via placenta or breast milk). These codes reflect the systemic developmental impacts caused by prenatal exposure to the drug thalidomide. What are the primary clinical features of Victims of Thalidomide? Victims of Thalidomide typically present with a specific pattern of malformations, most notably phocomelia, where the long bones of the limbs are shortened or absent.
ICD10 code of Victims of Thalidomide and ICD9 code
ICD-10 and ICD-9 codes for Victims of Thalidomide, with classification details for clinicians, coders and patients.
The medical classification for Victims of Thalidomide is primarily coded under ICD-10-CM code Q83.8 (Other congenital malformations of breast) or more broadly under external cause codes like Y43.2 (Adverse effects of drugs), while the legacy ICD-9-CM code is 760.72 (Noxious influences affecting fetus via placenta or breast milk). These codes reflect the systemic developmental impacts caused by prenatal exposure to the drug thalidomide.
What are the primary clinical features of Victims of Thalidomide?
Victims of Thalidomide typically present with a specific pattern of malformations, most notably phocomelia, where the long bones of the limbs are shortened or absent. Because thalidomide was administered during the early stages of pregnancy, the clinical impact on Victims of Thalidomide often extends beyond limb reduction to include ear malformations (such as microtia), cranial nerve palsies, and cardiovascular or renal anomalies.
How are the effects of Thalidomide categorized?
The impact on Victims of Thalidomide is categorized by the timing of exposure during the first trimester. Clinical documentation for Victims of Thalidomide generally highlights the following spectrum of developmental disruptions:
- Limb reduction defects: Including amelia (absence of limbs) and phocomelia.
- Sensory and neurological issues: Hearing loss or impairment due to external ear deformities.
- Internal organ involvement: Congenital heart defects and structural anomalies of the digestive or urinary tracts.
- Ocular anomalies: Microphthalmia or other vision-related developmental challenges.
Is there support for the Thalidomide community?
Living as one of the Victims of Thalidomide often requires multidisciplinary care, including orthopedic, audiological, and psychological support. At DiseaseMaps.org, we recognize the unique journey of those affected; currently, our community includes members who share lived experiences, providing a space for Victims of Thalidomide to connect with others navigating the long-term physical and social consequences of this historical medical tragedy.
Next steps
- Consult with a medical geneticist or a physiatrist experienced in managing adult survivors of congenital limb differences.
- Connect with global advocacy groups such as the Thalidomide Society to access resources and peer support.
- Join the DiseaseMaps.org community to share your experience and find others affected by these specific developmental conditions.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Thalidomide embryopathy.
- Orphanet: Congenital limb malformation (ORPHA:99974).
- World Health Organization (WHO): ICD-10 International Classification of Diseases.
- The Thalidomide Society: Medical and support resources for survivors.
